|1|Associations of dysnatremias with mortality in chronic kidney disease. (27220754)
Huang H.... Navaneethan S.D.
|2|Intragenic duplication in the PHKD1 gene in autosomal recessive polycystic kidney disease. (26502924)
Miyazaki J.... Fujii T.
|3|A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease. (24611717)
Kurashige M.... Maeda S.
|4|Endovascular Treatment of Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease. (26492429)
Jung S.C.... Han M.H.
|5|New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. (26546139)
Yang B.... Mao Z.
|6|Identification of Novel Glycans with Disialylated Structures in I+3 Integrin from Mouse Kidney Cells with the Phenotype of Polycystic Kidney Disease. (25300029)
Zhang A.F.... Kreidberg J.A.
|7|Interleukin-6 and vitamin D status during high-intensity resistance training in patients with chronic kidney disease. (24800209)
Molsted S.... Harrison A.P.
|8|Bilateral nephrectomy significantly improves health-related quality of life in a hemodialysis patient with autosomal dominant polycystic kidney disease. (24041611)
Chao C.T.... Kao T.W.
|9|Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. (23432795)
Chambrone L.... Romito G.A.
Herrera-Anazco P.... Hernandez A.V.
|11|Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus. (23355027)
Yap Y.S.... Liu Y.C.
|12|Pregnancy management and outcome in women with chronic kidney disease. (24376324)
Bili E.... Tarlatzis B.
|13|Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma-to strengthen the case toward renal replacement therapy? (25356216)
Latus J.... Braun N.
|14|Klotho and chronic kidney disease. (23652549)
Hu M.C.... Moe O.W.
|15|Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease. (23617397)
Sumida K.... Ohashi K.
|16|High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria. (23860441)
Ulasi I.I.... Skorecki K.
|17|Increased accumulation of CD16+ monocytes at local sites of inflammation in patients with chronic kidney disease. (24111715)
Wallquist C.... Jacobson S.H.
|18|Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. (23045430)
Iyoda M.... Akizawa T.
|19|Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. (24380085)
Chen S.C.... Tseng C.H.
|20|Periodontal disease: a covert source of inflammation in chronic kidney disease patients. (23840952)
Ismail G.... Ismail F.B.
|21|Potential for Biomarkers of Chronic Kidney Disease-Mineral Bone Disorder to Improve Patient Care. (24335564)
Alderson H.V.... Kalra P.A.
|22|Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. (22809658)
Noone D.G.... Marks S.D.
|23|Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy. (23391537)
Hawfield A.... Smith R.J.
|24|Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation. (21744088)
Syro L.V.... Harris P.C.
|25|Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort. (21941205)
Sim J.J.... Kalantar-Zadeh K.
|26|Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. (21325350)
Crawford A.... Geraghty D.P.
|27|Urinary type IV collagen in nondiabetic kidney disease. (20699621)
Furumatsu Y.... Rakugi H.
|28|The spectrum of polycystic kidney disease in children. (21896375)
|29|Endothelin, hypertension and chronic kidney disease: new insights. (20051851)
|30|Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. (20199663)
Rigalleau V.... Gin H.
|31|Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. (19643310)
Edwards N.C.... Townend J.N.
|32|Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition. (19556043)
Stoycheff N.... Levey A.S.
|33|Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease. (19273592)
Kang H.S.... Jetten A.M.
|34|Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin. (18786076)
Tagboto S.... Pugh-Clarke K.
|35|Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. (17890852)
Xie Y.... Chen X.
|36|Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. (18003767)
Andrade J.... Sirrs S.
|37|Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. (18712038)
Nakamura T.... Node K.
|38|The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. (17045221)
Chalmers L.... Bamgbola O.
|39|Darbepoetin alfa: its use in anemia associated with chronic kidney disease. (16207074)
Robinson D.M.... Easthope S.E.
|40|Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. (15662537)
Mak R.H.... Marks D.L.
|41|Molecular basis of autosomal dominant polycystic kidney disease. (15900113)
Al-Bhalal L.... Akhtar M.
|42|Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. (15149341)
Agarwal R.... Chase S.
|43|The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease. (12803511)
Hassan K.... Kristal B.
|44|A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. (12421721)
Liu S.... Beier D.R.
|45|Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. (11854326)
Hou X.... Guay-Woodford L.M.
Griffin M.D.... Kumar R.
|47|Transcatheter embolization for retroperitoneal hemorrhage secondary to acquired cystic kidney disease. (9007814)
Friedberg E.B.... Westby G.R.
|48|Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis. (8556834)
Marder K.... Schuppan D.
|49|Urothelial neoplasia complicating acquired cystic kidney disease. (1336142)
Rahilly M.A.... Carey F.A.
|50|Comparative effects of germfree and ambient environments on the development of cystic kidney disease in CFWwd mice. (6699465)
Werder A.A.... Wolfe G.H.